Buscar
30/11/2023
Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes
Frontino, G, Succurro, E, Corcoy, R, Scialabba, F, Poloniato, A, Scavini, M. Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1270472. PMID:38098867. IF:3.900(Q2/3D).
22/11/2023
Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review
Pérez, A, Redondo-Antón, J, Romera, I, Lizán, L, Santos, MRD, Díaz-Cerezo, S, Orozco-Beltran, D. Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review. Diabetes Therapy. 2023; DOI:10.1007/s13300-023-01503-4. PMID:37989829. IF:2.800(Q3/6D).
15/11/2023
Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves
Mauricio, D, Gratacòs, M, Franch-Nadal, J. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovascular Diabetology. 2023; 22(1)DOI:10.1186/s12933-023-02056-3. PMID:37968679. IF:8.500(Q1/1D).
10/08/2023
Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control
García E., Gil P., Miñambres I., Benitez-Amaro A., Rodríguez C., Claudi L., Julve J., Benitez S., Sánchez-Quesada J.L., Rives J., Garcia-Moll X., Vilades D., Perez A., Llorente-Cortes V.. Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1236487. PMID:37635956. IF:3.900(Q2/3D).
09/07/2023
Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms
Torres-Méndez J.K., Niño-Narvión J., Martinez-Santos P., Diarte-Añazco E.M.G., Méndez-Lara K.A., del Olmo T.V., Rotllan N., Julián M.T., Alonso N., Mauricio D., Camacho M., Muñoz J.P., Rossell J., Julve J.. Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms. Nutrients. 2023; 15(14)DOI:10.3390/nu15143083. PMID:37513501. IF:4.800(Q1/2D).
16/06/2023
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?
Velilla, TA, Guijarro, C, Ruiz, RC, Piñero, MR, Marcos, JF, Pérez, AP, López, AMB, López, AM, Donaire, JAG, Obaya, JC, Guerra, LC, Carratalá, VP, Cabello, IE, Lazo, MS, Rodrigo, MMC, Prieto, JMM, Doblas, JJG, Soto, AB. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2023; 4(2)DOI:10.1515/almed-2023-0047. PMID:38075943. IF:(Q/D).
10/03/2023
Obesity and fertility. Position statement.
Miñambres I, de Hollanda A, Vilarrasa N, Pellitero S, Rubio MA, Flores L, Caixàs A, Lobo S, Martinez Salamanca JI, Acevedo B, Moizé V, Andreu A, Escalada J. Obesity and fertility. Position statement.. Endocrinologia Diabetes y Nutricion. 2023; 70 Suppl 1DOI:10.1016/j.endien.2023.03.003. PMID:36907798. IF:(Q/D).
01/01/2023
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.02.002. PMID:37268528. IF:1.800(Q3/8D).
01/01/2023
Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2023; 4(2)DOI:10.1515/almed-2023-0010. PMID:. IF:(Q/D).
01/01/2023
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Cirugia Cardiovascular. 2023; 30(3)DOI:10.1016/j.circv.2023.02.001. PMID:. IF:(Q/D).
01/01/2023
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?
Velilla T.A., Guijarro C., Ruiz R.C., Piñero M.R., Marcos J.F.V., Pérez A.P., López M.A.B., López A.M., Donaire J.A.G., Obaya J.C., Guerra L.C., Carratalá V.P., Cabello I.E., Lazo M.S., Rodrigo M.M.C., Prieto J.M.M., Doblas J.J.G., Soto A.B.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?. Neurology Perspectives. 2023; 3(2)DOI:10.1016/j.neurop.2023.100126. PMID:. IF:(Q/D).
01/01/2023
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories
Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. Rec: Cardioclinics. 2023; 58(2)DOI:10.1016/j.rccl.2022.11.004. PMID:. IF:(Q/D).
01/01/2023
Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital
Bellido V., Freckman G., Pérez A., Galindo R.J.. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital. Endocrine Practice. 2023; 29(11)DOI:10.1016/j.eprac.2023.06.007. PMID:37369291. IF:3.700(Q2/4D).
01/01/2023
NAD+ Precursors: A Physiological Reboot?
Niño-Narvión J., Camacho M., Julve J.. NAD+ Precursors: A Physiological Reboot?. Nutrients. 2023; 15(20)DOI:10.3390/nu15204479. PMID:. IF:(Q/D).
05/11/2025
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries
Lazarus, JV, Agirre-Garrido, L, Miralles-Sanchez, JE, Manolas, MI, Tacke, F, Villela-Nogueira, CA, Al-Omar, HA, Alqahtani, SA, Alzubaidi, LMY, Bansal, M, Cusi, K, Isaacs, SD, Mauricio, D, Miyake, T, Moreira, RO, Nakazawa, S, Pannain, S, Pericàs, JM, Roden, M, Takahashi, H, Brachowicz, N. Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries. LIVER INTERNATIONAL. 2025; 45(12)DOI:10.1111/liv.70390. PMID:41194401. IF:5.200(Q1/2D).
01/11/2025
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council
Giorgino, F, Alzaid, F, Stoian, AP, Chan, JCN, Ji, LN, Lumu, W, Manrique, H, Mauricio, D, Saboo, B, Senior, PA, Yabe, D, Zoungas, S, Meireles, M, Mathieu, C, Czupryniak, L. Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council. DIABETOLOGIA. 2025; 68(11)DOI:10.1007/s00125-025-06504-5. PMID:40928674. IF:10.200(Q1/1D).
01/11/2025
Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP
Martinez-Brocca, MA, Bellido, V, Cardona-Hernandez, R, Castaño, L, Conget, I, Fernández, A, Gila, ALG, Leiva-Gea, I, Mauricio, D. Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:10.1016/j.endinu.2025.501639. PMID:41111054. IF:1.800(Q3/8D).
24/10/2025
Participant characteristics in the effectiveness of lifestyle interventions to optimize gestational weight gain: a systematic review and meta-analysis
Takele, WW, Redman, LM, Liu, K, Quinteros, A, Ukke, GG, Tobias, DK, Merino, J, Ahmad, A, Aiken, C, Benham, JL, Bodhini, D, Clark, AL, Colclough, K, Corcoy, R, Cromer, SJ, Duan, DSY, Felton, JL, Francis, EC, Gillard, P, Gingras, V, Gaillard, R, Haider, E, Hughes, A, Ikle, JM, Jacobsen, LM, Kahkoska, AR, Kettunen, JLT, Kreienkamp, RJ, Lim, LL, Männistö, JME, Massey, R, Mclennan, NM, Miller, RG, Morieri, ML, Most, J, Naylor, RN, Ozkan, B, Patel, KA, Pilla, SJ, Prystupa, K, Raghavan, S, Rooney, MR, Schön, M, Semnani-Azad, Z, Sevilla-Gonzalez, M, Svalastoga, P, Tam, CH, Thuesen, ACB, Tosur, M, Wallace, AS, Wang, CC, Wong, JJ, Yamamoto, JM, Young, K, Amouyal, C, Andersen, MK, Bonham, MP, Chen, ML, Cheng, FF, Chikowore, T, Chivers, SC, Clemmensen, C, Dabelea, D, Dawed, AY, Deutsch, AJ, Dickens, LT, Dimeglio, LA, Dudenhöffer-Pfeifer, M, Evans-Molina, C, Fernández-Balsells, MM, Fitipaldi, H, Fitzpatrick, SL, Gitelman, SE, Goodarzi, MO, Grieger, JA, Guasch-Ferré, M, Habibi, N, Hansen, T, Huang, CG, Harris-Kawano, A, Ismail, HM, Hoag, B, Johnson, RK, Jones, AG, Koivula, RW, Leong, A, Leung, GKW, Libman, IM, Long, SA, Lowe, WL, Morton, RW, Motala, AA, Onengut-Gumuscu, S, Pankow, JS, Pathirana, M, Pazmino, S, Perez, D, Petrie, JR, Powe, CE, Jain, R, Ray, D, Ried-Larsen, M, Saeed, Z, Santhakumar, V, Kanbour, S, Sarkar, S, Monaco, GSF, Scholtens, DM, Selvin, E, Sheu, WHH, Speake, C, Stanislawski, MA, Steenackers, N, Steck, AK, Stefan, N, Stoy, J, Taylor, R, Tye, SC, Ukke, GG, Urazbayeva, M, van der Schueren, B, Vatier, C, Wentworth, JM, Hannah, W, White, SL, Yu, GC, Zhang, YC, Zhou, SJ, Beltrand, J, Polak, M, Aukrust, I, de Franco, E, Flanagan, SE, Maloney, KA, Mcgovern, A, Molnes, J, Nakabuye, M, Njolstad, PR, Pomares-Millan, H, Provenzano, M, Saint-Martin, C, Zhang, CL, Zhu, YY, Auh, S, de Souza, R, Fawcett, AJ, Gruber, C, Mekonnen, EG, Mixter, E, Sherifali, D, Eckel, RH, Nolan, JJ, Philipson, LH, Brown, RJ, Billings, LK, Boyle, K, Costacou, T, Dennis, JM, Florez, JC, Gloyn, AL, Gomez, MF, Gottlieb, PA, Greeley, SAW, Griffin, K, Hattersley, AT, Hirsch, IB, Hivert, MF, Hood, KK, Josefson, JL, Kwak, SH, Laffel, LM, Lim, SS, Loos, RJF, Ma, RCW, Mathieu, C, Mathioudakis, N, Meigs, JB, Misra, S, Mohan, V, Murphy, R, Oram, R, Owen, KR, Ozanne, SE, Pearson, ER, Perng, W, Pollin, TI, Pop-Busui, R, Pratley, RE, Redondo, MJ, Reynolds, RM, Semple, RK, Sherr, JL, Sims, EK, Sweeting, A, Tuomi, T, Udler, MS, Vesco, KK, Vilsboll, T, Wagner, R, Rich, SS, Franks, PW, Josefson, J, Lim, S. Participant characteristics in the effectiveness of lifestyle interventions to optimize gestational weight gain: a systematic review and meta-analysis. Communications Medicine. 2025; 5(1)DOI:10.1038/s43856-025-01049-5. PMID:41136661. IF:(Q/D).
14/10/2025
ApoJ and apoL1 as novel determinants of MASH: a cross-sectional study
Cai, ZC, Najib, S, Núñez-Sánchez, MA, Martínez-Sánchez, MA, García-Melgares, C, Viguerie, N, Rossell, J, Julve, J, Croyal, M, Oliveira, AR, Martínez, CM, Dumas, SJ, Genoux, A, Frutos, MD, Ramos-Molina, B, Martinez, LO. ApoJ and apoL1 as novel determinants of MASH: a cross-sectional study. Lipids in Health and Disease. 2025; 24(1)DOI:10.1186/s12944-025-02733-0. PMID:41088161. IF:4.200(Q1/3D).
14/10/2025
Association between dietary niacin intake and diabetic retinopathy in a Catalonian population: a cross-sectional study
Torres-Méndez, JK, Rojo-López, MI, Antentas, M, Vendrell, P, Ortega, E, Alonso, N, Castelblanco, E, Muscarà, A, Rubinat, E, Alcubierre, N, Hernández, M, Rossell, J, Granado-Casas, M, Mauricio, D, Julve, J. Association between dietary niacin intake and diabetic retinopathy in a Catalonian population: a cross-sectional study. Frontiers in Nutrition. 2025; 12DOI:10.3389/fnut.2025.1626379. PMID:41164367. IF:5.100(Q1/2D).
10/10/2025
Impact of the new EASO obesity definition on the detection of atheromatosis in subjects with low-to-moderate cardiovascular risk
León-Mengíbar, J, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro-Boqué, E, Fernández, E, Caixàs, A, Bueno, M, Ciudin, A, Hernández, M, Simó, R, Hernández, C, Lecube, A. Impact of the new EASO obesity definition on the detection of atheromatosis in subjects with low-to-moderate cardiovascular risk. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1689960. PMID:41141356. IF:4.600(Q1/3D).
01/10/2025
The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024)
Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024). MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2025; 608DOI:10.1016/j.mce.2025.112626. PMID:40750504. IF:3.600(Q2/4D).
01/10/2025
Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans
Ma, CX, Ma, XN, Li, HL, Mauricio, D, Fu, SB. Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02938-8. PMID:41035032. IF:10.600(Q1/1D).
01/10/2025
Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study
Alarcón, PP, Alvarez, ED, Goitia, CL, Rodríguez, MM, Urbon, L, Maldonado, A, García, S, Serrallonga, NB, Aviño, LR, Palomar, JMR, Lopez, JG, Hoyas, CIN, Corcoy, R, Raimond, TM, López, ML, Madorell, BS, Hernández, M, Kyriakos, G, Bellas, LC, Borrás, JG, Servant, OS, Colet, AM, Serrano, C, Contreras, C, Román, AR, Díez, M, Veladesojo, A, Andujar, P, Diez, A, Galiana, PA, Peris, BP, Fernandez, E, Ferrer, M, Alfonso, FJG, Torre, ELM. Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study. Diabetes Technology & Therapeutics. 2025; 27(10)DOI:10.1177/15209156251363452. PMID:40729095. IF:6.300(Q1/2D).
01/10/2025
Executive summary of the document 'Diabetes Day Hospital. Value proposition'
Martin, FJES, Lesmes, IB, Peralta, FG, Torres, JFM, Gómez, FP, Ballesteros, AC, González-Clemente, JM, de Villar, NGP, Portillo, CM, Corrales, PJP, Engel, WR, de Inestrosa, MTBP, Fernández-Santos, CM, Arranz, E, Vinagre, GF, Perán, JF, Sedisa, Brocca, MAM. Executive summary of the document 'Diabetes Day Hospital. Value proposition'. Endocrinologia Diabetes y Nutricion. 2025; 72(8)DOI:10.1016/j.endien.2025.501601. PMID:40946027. IF:1.800(Q3/8D).
19/09/2025
Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study
Puig, R, Rojo-López, MI, Julve, J, Castelblanco, E, Ponomarenko, J, Amezqueta, S, Vendrell, J, Franch-Nadal, J, Torres, JL, Mauricio, D, Ramos-Romero, S. Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study. Nutrients. 2025; 17(18)DOI:10.3390/nu17183003. PMID:41010528. IF:5.000(Q1/2D).
18/09/2025
Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes
Milad, C, Viñals, C, Perea, V, Seres-Noriega, T, Blanco-Carrasco, A, Vinagre, I, Claro, M, Solà, C, Mesa, A, Ayala, D, Conget, I, Gimenez, M, Amor, AJ. Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes. DIABETES-METABOLISM RESEARCH AND REVIEWS. 2025; 41(6)DOI:10.1002/dmrr.70088. PMID:40965235. IF:6.000(Q1/2D).
03/09/2025
Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change
Páez-Espinosa, EV, Sosa-Guzmán, DM, Buitrón-Andrade, LR, Dávila-Jumbo, N, Cáceres-Ruiz, MI, Robalino-Flores, VF, Mato-Matute, E. Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change. Tropical Medicine and Infectious Disease. 2025; 10(9)DOI:10.3390/tropicalmed10090254. PMID:41003564. IF:2.600(Q1/1D).
01/09/2025
A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries
Voss, EA, Yuan, Z, Ali, SR, Bosan, R, Eworuke, E, Brewster, J, Vlacho, B, Fernández-Camins, B, Fernández-Bertolín, S, Fonseca, S, Jeffcoat, C, Wang, L. A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries. DIABETES OBESITY & METABOLISM. 2025; 27(9)DOI:10.1111/dom.16574. PMID:40605139. IF:5.700(Q1/2D).
01/09/2025
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(9)DOI:10.1210/clinem/dgaf288. PMID:40652453. IF:5.100(Q1/2D).
25/08/2025
Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes
Viñals, C, Conget, I, Granados, M, Solà, C, Ayala, D, Mesa, A, Seres-Noriega, T, Domenech, M, Perea, V, Blanco, J, Vinagre, I, Gimenez, M, Amor, AJ. Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes. Journal of Clinical Medicine. 2025; 14(17)DOI:10.3390/jcm14176004. PMID:40943764. IF:2.900(Q1/2D).
01/08/2025
Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes
Claro, M, Viñals, C, Giménez, M, Perea, V, Granados, M, Serés-Noriega, T, Blanco, J, Vinagre, I, Mesa, A, Milad, C, Ayala, D, Solà, C, Esmatjes, E, Conget, I, Amor, AJ. Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112334. PMID:40543571. IF:7.400(Q1/1D).
01/08/2025
European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines
Karagiannis, T, Advani, A, Davies, MJ, Del Prato, S, Dinneen, SF, Kuss, O, Lorenzoni, V, Mathieu, C, Mauricio, D, Tankova, T, Zaccardi, F, Holt, RIG, Tsapas, A, EASD Guidelines Oversight Comm. European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines. DIABETOLOGIA. 2025; 68(8)DOI:10.1007/s00125-025-06370-1. PMID:40447848. IF:10.200(Q1/1D).
01/08/2025
Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes
Chico, A, Pazos-Couselo, M, Nattero-Chavez, L, Simó-Servat, O, Durán-Martínez, M, Ugarte-Abasolo, E, Aguilera, E, Andía, V, Moreno-Fernández, J, Granados, M, Rebollo, A, Fernandez-Rubio, E, Quirós, C, Alpañés, M, Márquez, R, Beato-Vibora, P, Lado-Baleato, O, Picón-César, M. Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112377. PMID:40695413. IF:7.400(Q1/1D).
01/08/2025
Mitochondrial dysfunction and endoplasmic reticulum stress in atherosclerotic degenerative ascending aortic aneurysm: A transcriptomic analysis
Almendra-Pegueros, R, Barros-Membrilla, A, Perez-Marlasca, E, Tabilo-Ahumada, J, Julve, J, Sanchez-Quesada, JL, Medina-Gómez, G, Martínez-González, JE, Rodríguez, C, Galán, M. Mitochondrial dysfunction and endoplasmic reticulum stress in atherosclerotic degenerative ascending aortic aneurysm: A transcriptomic analysis. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
11/07/2025
Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value
Merino, M, Maravilla-Herrera, P, Artola, S, Escalada, J, Pérez, A, Remón, J, Trillo-Mata, JL, Vallès-Callol, JA, Hidalgo-Vega, A. Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value. Frontiers in Public Health. 2025; 13DOI:10.3389/fpubh.2025.1511108. PMID:40717941. IF:3.400(Q1/2D).
01/07/2025
GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease
Sardà, H, Genua, I, Miñambres, I. GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease. MEDICINA CLINICA. 2025; 165(1)DOI:10.1016/j.medcli.2025.106951. PMID:40378625. IF:2.100(Q2/3D).
01/07/2025
Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm
Almendra-Pegueros, R, Barros-Membrilla, AJ, Pérez-Marlasca, E, Julve, J, Martinez-González, J, Rodriguez, C, Galán, M. Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm. Clinica E Investigacion En Arteriosclerosis. 2025; 37(4)DOI:10.1016/j.arteri.2024.09.002. PMID:39424523. IF:(Q/D).
01/07/2025
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2025; 193(1)DOI:10.1093/ejendo/lvaf116. PMID:40652450. IF:5.200(Q1/2D).
01/07/2025
The People-First Liver Charter
Lazarus, JV, Wajcman, DI, Pannain, S, Brennan, PN, Manolas, MI, Jepsen, P, Treloar, C, Arora, AK, Matthews, PC, Picchio, CA, White, TM, Grebely, J, Vaz, J, Hagström, H, Rabin, KH, Isaacs, S, Ribeiro, RT, Roden, M, Betel, M, Willemse, J, Díaz, LA, Allen, AM, Alkhouri, N, Schattenberg, JM, Mauricio, D, Rinella, ME, Pose, E, Tsochatzis, EA, Ninburg, M, Cusi, K, Alazawi, W, Duseja, A, Frühbeck, G, Lofton, H, Jaisinghani, P, Kanwal, F, Shiha, G, Zelber-Sagi, S, Holden, L, Villota-Rivas, M. The People-First Liver Charter. NATURE MEDICINE. 2025; 31(7)DOI:10.1038/s41591-025-03759-8. PMID:40473951. IF:50.000(Q1/1D).
06/06/2025
Circulating short-chain fatty acids and Mediterranean food patterns. A potential role for the prediction of type 2 diabetes risk: The Di@bet.es Study
Llauradó, G, Cedo, L, Climent, E, Badia, J, Rojo-Martínez, G, Roux, JFL, Yanes, O, Vinaixa, M, Granado-Casas, M, Mauricio, D, Fernández-Veledo, S, Vendrell, J. Circulating short-chain fatty acids and Mediterranean food patterns. A potential role for the prediction of type 2 diabetes risk: The Di@bet.es Study. BMC Medicine. 2025; 23(1)DOI:10.1186/s12916-025-04186-9. PMID:40481510. IF:8.300(Q1/1D).
27/05/2025
Novel Experimental Dietary Supplementations to Combat Metabolic Alterations in Diabetes
Rossell, J, Julve, J. Novel Experimental Dietary Supplementations to Combat Metabolic Alterations in Diabetes. Nutrients. 2025; 17(11)DOI:10.3390/nu17111816. PMID:40507085. IF:5.000(Q1/2D).
21/05/2025
Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis
Mesa, A, Franch-Nadal, J, Navas, E, Mauricio, D. Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02791-9. PMID:40399939. IF:10.600(Q1/1D).
15/05/2025
A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data
Manzini, E, Vlacho, B, Franch-Nadal, J, Escudero, J, Génova, A, Reixach, E, Andrés, E, Pizarro, I, Mauricio, D, Perera-Lluna, A. A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data. EXPERT SYSTEMS WITH APPLICATIONS. 2025; 274DOI:10.1016/j.eswa.2025.126876. PMID:. IF:7.500(Q1/1D).
01/05/2025
Managing diabetes across female reproductive stages
Mauricio, D, Gratacòs, M, Franch-Nadal, J. Managing diabetes across female reproductive stages. TRENDS IN ENDOCRINOLOGY AND METABOLISM. 2025; 36(5)DOI:10.1016/j.tem.2025.02.003. PMID:40089417. IF:12.600(Q1/1D).
09/04/2025
Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study
Mesa, A, Puig-Jove, C, Pané, A, Vinagre, I, López-Quesada, E, Meler, E, Alonso-Carril, N, Quirós, C, Amor, AJ, Perea, V. Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02719-3. PMID:40205402. IF:10.600(Q1/1D).
02/04/2025
Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes
Barranco-Altirriba, M, Rossell, J, Alonso, N, Weber, RJM, Ortega, E, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Winder, C, Junza, A, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02701-z. PMID:40176064. IF:10.600(Q1/1D).
01/04/2025
Transitioning between automated insulin delivery systems: A focus on personalisation
Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Azriel-Mira, S, Nattero-Chávez, L, Mora, RV, Alonso-Carril, N, Simó-Servat, O, Aguilera-Hurtado, E, Céspedes, LMR, de Adana, MR, Domínguez, M, Márquez-Pardo, R, Díaz-Soto, G, Martínez-Brocca, MA, Fernández, KA, Buesa, MA, Hernández, MC, Quirós, C. Transitioning between automated insulin delivery systems: A focus on personalisation. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 222DOI:10.1016/j.diabres.2025.112070. PMID:40020785. IF:7.400(Q1/1D).
01/04/2025
Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study
Antonio-Arques, V, Camins, BF, Vlacho, B, Barrot, J, Pérez, JN, Torre, EM, Mauricio, D, Franch-Nadal, J. Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study. Endocrinologia Diabetes y Nutricion. 2025; 72(4)DOI:10.1016/j.endien.2025.501543. PMID:40180835. IF:1.800(Q3/8D).
01/03/2025
Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app
Cuixart, G, Corcoy, R, González, C. Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app. Hormones-International Journal of Endocrinology and Metabolism. 2025; 24(1)DOI:10.1007/s42000-024-00609-z. PMID:39412732. IF:2.500(Q3/7D).
21/02/2025
Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study
Amigó, N, Castelblanco, E, Julve, J, Martínez-Micaelo, N, Alonso, N, Hernández, M, Ribalta, J, Guardiola, M, Torán-Monserrat, P, Lopez-Lifante, V, Herrero-Alonso, C, Arteaga, I, Ortega, E, Franch-Nadal, J, Mauricio, D. Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02636-5. PMID:39985069. IF:10.600(Q1/1D).
01/02/2025
Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet
Summer, S, Borrell-Pages, M, Bruno, RM, Climie, RE, Dipla, K, Dogan, A, Eruslanova, K, Fraenkel, E, Mattace-Raso, F, Pugh, CJA, Rochfort, KD, Ross, M, Roth, L, Schmidt-Trucksaess, A, Schwarz, D, Shadiow, J, Sohrabi, Y, Sonnenberg, J, Tura-Ceide, O, Tuna, BG, Julve, J, Dogan, S. Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet. GeroScience. 2025; 47(1)DOI:10.1007/s11357-024-01467-8. PMID:39725804. IF:5.400(Q1/1D).
01/02/2025
Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society
Pedro-Botet, J, Arrieta, F, Botana, M, Gimeno-Orna, JA, Martinez-Montoro, JI, de Victoria, EOM, Ribalta, J, Sánchez-Margalet, V, Pérez-Pérez, A. Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society. Endocrinologia Diabetes y Nutricion. 2025; 72(2)DOI:10.1016/j.endien.2025.101523. PMID:39924389. IF:1.800(Q3/8D).
30/01/2025
Expert consensus on vitamin D in osteoporosis
Lei, S, Zhang, XY, Song, LG, Wen, JH, Zhang, Z, Tian, JQ, Yang, R, Xu, SH, Qiu, SH, Macisaac, RJ, Aleksova, J, Mac-Way, F, Dupuis, ME, Benaiges, D, Mauricio, D, Sommer, AP, Barzilay, JI, Gallagher, JC, Pan, LL, Ji, LL, Fang, P, Li, Y, Liu, Q, Zhao, JS, Xue, Y, Shen, YQ, Wang, LM, Han, JF, Liu, GH. Expert consensus on vitamin D in osteoporosis. Annals Of Joint. 2025; 10DOI:10.21037/aoj-24-48. PMID:39981430. IF:(Q/D).
15/02/2024
Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.
Genua I, Cusi K. Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.. Diabetes Spectrum : A Publication Of The American Diabetes Association. 2024; 37(1)DOI:10.2337/dsi23-0012. PMID:38385098. IF:(Q/D).
01/02/2022
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
Gil, J, Marques-Pamies, M, Valassi, E, Garcia-Martinez, A, Serra, G, Hostalot, C, Fajardo-Montanana, C, Carrato, C, Bernabeu, I, Marazuela, M, Rodriguez-Lloveras, H, Camara, R, Salinas, I, Lamas, C, Biagetti, B, Simo-Servat, A, Webb, SM, Pico, A, Jorda, M, Puig-Domingo, M. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response. Biomedicines. 2022; 10(2)DOI:10.3390/biomedicines10020460. PMID:35203668. IF:4.700(Q1/3D).
01/12/2021
Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly
Losa, M, Resmini, E, Barzaghi, LR, Albano, L, Bailo, M, Webb, SM, Mortini, P. Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly. CLINICAL ENDOCRINOLOGY. 2021; 95(6)DOI:10.1111/cen.14547. PMID:34219264. IF:3.523(Q3/7D).
01/12/2021
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M, Auchus, R, Bancos, I, Ben-Shlomo, A, Bertherat, J, Biermasz, NR, Boguszewski, CL, Bronstein, MD, Buchfelder, M, Carmichael, JD, Casanueva, FF, Castinetti, F, Chanson, P, Findling, J, Gadelha, M, Geer, EB, Giustina, A, Grossman, A, Gurnell, M, Ho, K, Ioachimescu, AG, Kaiser, UB, Karavitaki, N, Katznelson, L, Kelly, DF, Lacroix, A, McCormack, A, Melmed, S, Molitch, M, Mortini, P, Newell-Price, J, Nieman, L, Pereira, AM, Petersenn, S, Pivonello, R, Raff, H, Reincke, M, Salvatori, R, Scaroni, C, Shimon, I, Stratakis, CA, Swearingen, B, Tabarin, A, Takahashi, Y, Theodoropoulou, M, Tsagarakis, S, Valassi, E, Varlamov, EV, Vila, G, Wass, J, Webb, SM, Zatelli, MC, Biller, BMK. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes & Endocrinology. 2021; 9(12)DOI:10.1016/S2213-8587(21)00235-7. PMID:34687601. IF:44.867(Q1/1D).
01/09/2021
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy
Luger, A, Broersen, LHA, Biermasz, NR, Biller, BMK, Buchfelder, M, Chanson, P, Jorgensen, JOL, Kelestimur, F, Llahana, S, Maiter, D, Mintziori, G, Petraglia, F, Verkauskiene, R, Webb, SM, Dekkers, OM. ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021; 185(3)DOI:10.1530/EJE-21-0462. PMID:34425558. IF:6.558(Q1/2D).
01/09/2021
Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain
Iglesias, P, Nocete, I, Rodriguez, MDM, Venegas-Moreno, E, Ares, J, Biagetti, B, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Villar-Taibo, R, Cordido, F, Paja, M, Glerean, M, Rivera, NG, Fuentes, ED, Blanco, C, Alvarez-Escola, C, Martin, T, Webb, SM, Bernabeu, I, Villabona, C, Soto-Moreno, A, Gaztambide, S, Diez, JJ. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain. NEUROENDOCRINOLOGY. 2021; 111(10)DOI:10.1159/000512161. PMID:33040060. IF:5.135(Q2/4D).